Truncated RARα caused resistance to retinoids in an embryonal carcinoma cell line [67] whereas epithelial cells with different types of truncated RARα mutants were more sensitive to treatment with retinoic acid [68]. This evidence concerns the gene RARA and embryonal carcinoma.